Cardiovascular Magnetic Resonance Imaging in Myocardial Disease
- PMID: 38774162
- PMCID: PMC11107957
- DOI: 10.7759/cureus.58688
Cardiovascular Magnetic Resonance Imaging in Myocardial Disease
Abstract
Cardiovascular magnetic resonance (CMR) is the central non-invasive imaging investigation for the evaluation of myocardial disease. It is the well-established gold standard for measuring cardiac chamber volumes, systolic function, and left ventricular mass, and it brings unique information for therapeutic decisions. In addition, its tissue characterization capability, through T1, T2, and T2* mapping, as well as early and late gadolinium enhancement (LGE) sequences, allows to differentiate in many cases among ischemic, inflammatory, and infiltrative heart disease and permits the quantification of myocardial fibrosis, providing valuable diagnostic and prognostic information. This review aims to highlight the main CMR features of different cardiomyopathies.
Keywords: cardiology; cardiomyopathies; cardiovascular magnetic resonance imaging; late gadonlinium enhancement; myocardial disease.
Copyright © 2024, Popa et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Elliott P, Andersson B, Arbustini E, et al. Eur Heart J. 2008;29:270–276. - PubMed
-
- 2023 ESC Guidelines for the management of cardiomyopathies. Arbelo E, Protonotarios A, Gimeno JR, et al. Eur Heart J. 2023;44:3503–3626. - PubMed
-
- Dilated cardiomyopathy. Jefferies JL, Towbin JA. Lancet. 2010;375:752–762. - PubMed
-
- 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. McDonagh TA, Metra M, Adamo M, et al. Eur Heart J. 2021;42:3599–3726. - PubMed
Publication types
LinkOut - more resources
Full Text Sources